Description of Business and Basis of Presentation - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Description of Business and Basis of Presentation [Line Items] | |||||||
| Net aggregate proceeds | $ 391,550 | ||||||
| Cash, cash equivalents and marketable securities | $ 1,028,300 | 1,028,300 | |||||
| Working capital | 1,002,400 | 1,002,400 | |||||
| Accumulated deficit | (518,234) | (518,234) | $ (378,976) | ||||
| Net loss | (79,056) | $ (60,202) | $ (41,426) | $ (34,452) | (139,258) | $ (75,878) | |
| Cash flows from operations | (103,357) | $ (57,236) | |||||
| SafeGuard Healthcare, LLC [Member] | Convertible Promissory Note [Member] | |||||||
| Description of Business and Basis of Presentation [Line Items] | |||||||
| Principal amount of convertible promissory note including accrued interest | $ 26,800 | $ 26,800 | |||||
| Common Stock [Member] | |||||||
| Description of Business and Basis of Presentation [Line Items] | |||||||
| Common shares offering | 298,629 | 377,226 | 10,570 | 66,506 | |||
| X | ||||||||||
- Definition Cash, cash equivalents and marketable securities. No definition available.
|
| X | ||||||||||
- Definition Description of business and basis of presentation. No definition available.
|
| X | ||||||||||
- Definition Working capital. No definition available.
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|